USA flag logo/image

An Official Website of the United States Government

CURRENTLY THERE IS NO EFFECTIVE ORAL PROPHYLACTIC FOR THROMBOEMBOLIC DISORDERS.

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
3241
Program Year/Program:
1985 / SBIR
Agency Tracking Number:
3241
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Hepar Industries, Inc.
160 Industrial Drive, P.o. Box 338 Franklin, OH 45005
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1985
Title: CURRENTLY THERE IS NO EFFECTIVE ORAL PROPHYLACTIC FOR THROMBOEMBOLIC DISORDERS.
Agency: HHS
Contract: N/A
Award Amount: $50,000.00
 

Abstract:

CURRENTLY THERE IS NO EFFECTIVE ORAL PROPHYLACTIC FOR THROMBOEMBOLIC DISORDERS. AS A RESULT, AFFLICTED INDIVIDUALS MUST RECEIVE SINGLE OR MULTIPLE INJECTIONS OF MEDICATION EACH DAY. THE EFFECTIVENESS OF HEPARIN AS AN ANTICOAGULANT IS WELL KNOWN. HOWEVER, HEPARIN MUST BE ADMINISTERED BY INJECTION. THIS GRANT APPLICATION IS DIRECTED TOWARD THE DEVELOPMENT OF A HEPARIN DERIVATIVE PHASE I WILL DEMONSTRATE THE FEASIBILITY OF SYNTHESIZING HEPARIN DERIVATIVES WITH HYDROPHOBIC GROUPS, REPLACING A PORTION OF THE HYDROXYL GROUPS IN LOW MOLECULAR WEIGHT HEPARIN. IT IS EXPECTED THAT SUCH A DERIVATIVE WILL BE ORALLY ACTIVE AND HAVE INCREASED ANTITHROMBIC ACTIVITY IN RELATION TO ITS TENDENCY TO CAUSE BLEEDING. PHASE II RESEARCH WILL ENTAIL CONTINUED SYNTHETIC WORK AND IN VITRO CHARACTERIZATION AND IN VIVO TESTING OF THE DERIVATIVE HEPARINS IN ANIMALS AND IN HUMANS. HEPAR INDUSTRIES, WITH ITS EXPERIENCE IN THE MANUFACTURE OF USP HEPARIN, WOULD BE IN A POSITION TO MANUFACTURE AND MARKET THE NEW ORAL HEPARIN DEVELOPED IN THIS PROJECT.

Principal Investigator:

Kevin m. foley
PRINCIPAL INVESTIGATOR
5137463603

Business Contact:

Small Business Information at Submission:

Hepar Industries, Inc.
160 Industrial Drive, P.o. Box 338 Franklin, OH 45005

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No